AIBT OTC
Aibotics Inc.
1W: +120.0%
1M: +450.0%
3M: +214.3%
YTD: -13.7%
$0.00
+0.00 (+29.41%)
Weekly Expected Move ±56.4%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-03-30
Earliest Filing
2024-08-21
Latest Filing
investor: 1
acquirer: 1
target: 1
Counterparties (Filed by AIBT)
3 relationshipsCompanies named in AIBT's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Ehave Inc. | EHVVF | investor | Largest shareholder exchanging common stock for Series A Super Voting Stock | 2024-08-21 | View |
| Ehave, Inc. | EHVVF | acquirer | Acquired 75.77% of 20/20 Global stock and sold Mycotopia Therapies to 20/20 Global. | 2021-03-30 | View |
| Mycotopia Therapies Inc. | — | target | Acquired by 20/20 Global; became a wholly owned subsidiary. | 2021-03-30 | View |
Recent 8-K Filings (5)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2025-03-24 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2024-08-21 | Entry into Material Definitive Agreement; Amendments to Articles of Incorporation or Bylaws; Financi | Agreement | View |
| 2024-03-28 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2023-05-03 | Non-Reliance on Previously Issued Financial Statements | View | |
| 2021-03-30 | Completion of Acquisition or Disposition of Assets; Changes in Control of Registrant; Departure/Elec | Acquisition | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR